Targeting TGF–β for treatment of disease
- 1 October 1995
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 1 (10), 1000-1001
- https://doi.org/10.1038/nm1095-1000
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Tamoxifen elevates transforming growth factor–β and suppresses diet–induced formation of lipid lesions in mouse aortaNature Medicine, 1995
- The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosisNature Medicine, 1995
- Transforming Growth Factor β in Tissue FibrosisNew England Journal of Medicine, 1994
- Transforming growth factor beta: the good, the bad, and the ugly.The Journal of Experimental Medicine, 1994
- Loss of receptors for transforming growth factor beta in human T-cell malignancies.Proceedings of the National Academy of Sciences, 1994
- One systemic administration of transforming growth factor-beta 1 reverses age- or glucocorticoid-impaired wound healing.Journal of Clinical Investigation, 1993
- A major advance in the use of growth factors to enhance wound healing.Journal of Clinical Investigation, 1993
- Transforming Growth Factor β as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast CancerNew England Journal of Medicine, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration.The Journal of cell biology, 1991